{
    "startDate": "2018-01-01",
    "endDate": "2018-12-31",
    "year": "2018",
    "quarter": "FY",
    "symbol": "VKTX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 24779000
            },
            {
                "label": "Short-term investments \u2013 available for sale",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 276741000
            },
            {
                "label": "prepaid clinical trial and preclinical study costs.",
                "concept": "vktx:PrepaidClinicalTrialAndPreclinicalStudyCosts",
                "unit": "usd",
                "value": 335000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 278000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 302133000
            },
            {
                "label": "Deferred public offering and other financing costs noncurrent.",
                "concept": "vktx:DeferredPublicOfferingAndOtherFinancingCostsNoncurrent",
                "unit": "usd",
                "value": 150000
            },
            {
                "label": "Deposits",
                "concept": "DepositsAssetsNoncurrent",
                "unit": "usd",
                "value": 29000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 302312000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 959000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 3591000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4550000
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Liabilities, convertible notes and stockholders\u2019 equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4562000
            },
            {
                "label": "Commitments and contingencies (Note 11)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.00001 par value: 10,000,000 shares authorized at December 31, 2018 and 2017; no shares issued and outstanding at December 31, 2018 and 2017",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.00001 par value: 300,000,000 shares authorized at December 31, 2018 and 2017; 71,742,043 shares issued and outstanding at December 31, 2018 and 35,817,104 shares issued and outstanding at December 31, 2017",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 401090000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -102918000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -423000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 297750000
            },
            {
                "label": "Liabilities, convertible notes and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 302312000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -22063000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 404000
            },
            {
                "label": "Amortization of investment premiums",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 73000
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Amortization of non cash clinical trial costs.",
                "concept": "vktx:AmortizationOfNonCashClinicalTrialCosts",
                "unit": "usd",
                "value": 666000
            },
            {
                "label": "Change In fair value of debt conversion features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": 1398000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2608000
            },
            {
                "label": "Realized Gain Loss on Investmens.",
                "concept": "vktx:RealizedGainLossOnInvestmens",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 137000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -508000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1468000
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -18755000
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": 348204000
            },
            {
                "label": "Proceeds from sales and maturities of investments",
                "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
                "unit": "usd",
                "value": 82475000
            },
            {
                "label": "Cash flows from investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -265729000
            },
            {
                "label": "Proceeds from issuances of common stock, net of underwriting discounts and commissions",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 296607000
            },
            {
                "label": "Public offering and financing costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 765000
            },
            {
                "label": "Value of shares withheld related to employee tax withholding",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 127000
            },
            {
                "label": "Repayment of convertible notes payable",
                "concept": "RepaymentsOfConvertibleDebt",
                "unit": "usd",
                "value": 3833000
            },
            {
                "label": "Proceeds from stock issuance under employee stock purchase plan and warrant exercises.",
                "concept": "vktx:ProceedsFromStockIssuanceUnderEmployeeStockPurchasePlanAndWarrantExercises",
                "unit": "usd",
                "value": 8393000
            },
            {
                "label": "Cash flows from financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 300275000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 15791000
            },
            {
                "label": "Cash paid during the period for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 81000
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 19040000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 7121000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 26161000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -26161000
            },
            {
                "label": "Change In fair value of debt conversion features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": 1398000
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 404000
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Interest income, net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 3236000
            },
            {
                "label": "Realized loss on investments",
                "concept": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
                "unit": "usd",
                "value": -12000
            },
            {
                "label": "Other income (expense):",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 4098000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -22063000
            },
            {
                "label": "Unrealized loss on securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -403000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -22466000
            },
            {
                "label": "Basic and diluted net loss per share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.38
            },
            {
                "label": "Weighted-average shares used to compute basic and diluted net loss per share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 57580244
            }
        ]
    }
}